Sahil D. Doshi, Nazli Dizman, Antonio Ocejo, Andrea Knezevic, Maria Julia Moura Nascimento Santos, Andrew E. Cornish, Andrew Johns, Matthew T. Campbell, Ritesh R. Kotecha, Eric Jonasch, Neil J. Shah, Omar Alhalabi, Marie Carlo, Amishi Yogesh Shah, Darren R. Feldman, Pavlos Msaouel, Robert J. Motzer, Nizar M. Tannir, Andrew Warren Hahn, Martin H. Voss. "A multi-institution analysis of outcomes with first-line ipilimumab and nivolumab for 514 patients with metastatic clear cell renal cell carcinoma by number of doses.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.441